Edvinsson L, Erlinge D, Sun X Y, Hedner T
Department of Internal Medicine, University Hospital, Lund, Sweden.
Pharmacol Toxicol. 1994 Apr-May;74(4-5):193-201. doi: 10.1111/j.1600-0773.1994.tb01098.x.
Since the discovery of neuropeptide Y which is co-stored and co-operate with noradrenaline (NA) in sympathetic nerve fibers, several scientific groups have searched for structures with neuropeptide Y antagonistic properties. Research has mainly focused on various peptide fragments which originate from or are related to the neuropeptide Y sequence. Some non-peptide antagonists have been proposed but they are mostly of low potency and non-selective. Our recent observations that alpha-trinositol (D-myo-inositol 1.2.6-trisphosphate) is an inhibitor of neuropeptide Y effects will hopefully lead to the development of useful non-peptide neuropeptide Y inhibitors. As a novel approach the highly selective approach of down-regulating neuropeptide Y receptors with antisense oligodeoxynucleotides is also discussed. Neuropeptide Y antagonistic agents would help us to understand the physiological role of neuropeptide Y and may serve as useful medication in circulation disorders.
自从发现神经肽Y与去甲肾上腺素(NA)共同储存于交感神经纤维并协同作用以来,多个科研团队一直在寻找具有神经肽Y拮抗特性的结构。研究主要集中在源自神经肽Y序列或与之相关的各种肽片段上。已经提出了一些非肽类拮抗剂,但它们大多效力低且无选择性。我们最近观察到α-三磷酸肌醇(D-肌醇1,2,6-三磷酸)是神经肽Y效应的抑制剂,这有望促成有用的非肽类神经肽Y抑制剂的开发。作为一种新方法,还讨论了用反义寡脱氧核苷酸下调神经肽Y受体的高选择性方法。神经肽Y拮抗剂将有助于我们了解神经肽Y的生理作用,并可能成为治疗循环系统疾病的有用药物。